Related content

Administering radioiodine treatment; alternative to nuclear medicine prescribing

By Salvatori Massimo   Mansi Luigi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 9, 2007-09 ,pp. : 1512-1513

Springer Publishing Company

Access to resources Recommend Favorite

Nuclear medicine in the treatment of neuroendocrine tumours—problems and perspectives

By Grzela Tomasz   Bialoszewska Agata   Brawura-Biskupski-Samaha Robert  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 444-447

Springer Publishing Company

Access to resources Recommend Favorite

Comment on long-term risk in radioiodine treatment of hyperthyroidism

By Baldys-Waligorska Agata   Hubalewska-Dydejczyk Alicja  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1738-1739

Springer Publishing Company

Access to resources Recommend Favorite

Complementary alternative medicine and nuclear medicine

By Werneke Ursula   McCready V.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 4, 2004-04 ,pp. : 599-603

Springer Publishing Company

Access to resources Recommend Favorite

Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?

By Dottorini Massimo  

Clinical and Translational Imaging, Vol. 1, Iss. 3, 2013-06 ,pp. : 205-216

Springer Publishing Company

Access to resources Recommend Favorite